Literature DB >> 17420504

Treatment of chronic respiratory diseases in obese people.

Luca Mascitelli, Francesca Pezzetta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420504      PMCID: PMC1839784          DOI: 10.1503/cmaj.1060122

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

Review 1.  The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies.

Authors:  Magali Poulain; Mariève Doucet; Geneviève C Major; Vicky Drapeau; Frédéric Sériès; Louis-Philippe Boulet; Angelo Tremblay; François Maltais
Journal:  CMAJ       Date:  2006-04-25       Impact factor: 8.262

2.  ACE in COPD: a therapeutic target?

Authors:  R Forth; H Montgomery
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

3.  Effects of enalapril on erythrocytosis after renal transplantation.

Authors:  R S Gaston; B A Julian; A G Diethelm; J J Curtis
Journal:  Ann Intern Med       Date:  1991-12-15       Impact factor: 25.391

4.  Weight loss and the renin-angiotensin-aldosterone system.

Authors:  Stefan Engeli; Jana Böhnke; Kerstin Gorzelniak; Jürgen Janke; Petra Schling; Michael Bader; Friedrich C Luft; Arya M Sharma
Journal:  Hypertension       Date:  2005-01-03       Impact factor: 10.190

5.  Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial.

Authors:  Raul Plata; Arturo Cornejo; Carla Arratia; Agustina Anabaya; Annalisa Perna; Borislav D Dimitrov; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

Review 6.  Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Authors:  K P Marathias; B Agroyannis; T Mavromoustakos; J Matsoukas; D V Vlahakos
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.